CAS 1013920-15-4

Formule : C23H26FN5O3

InChI : InChI=1S/C23H26FN5O3/c1-12-19(10-17-16-9-14(24)5-6-18(16)27-21(17)30)25-13(2)20(12)22(31)26-15-7-8-29(11-15)23(32)28(3)4/h5-6,9-10,15,25H,7-8,11H2,1-4H3,(H,26,31)(H,27,30)/b17-10-/t15-/m0/s1

Code InChI : KMIOJWCYOHBUJS-HAKPAVFJSA-N

SMILES : CC1=C(NC(=C1C(=O)N[C@H]2CCN(C2)C(=O)N(C)C)C)/C=C\3/C4=C(C=CC(=C4)F)NC3=O

Vorolanib

CAS : 1013920-15-4

Vorolanib

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : ≥95%

Masse moléculaire : 439.48

Ref: 54-BUP04294

Vorolanib

CAS : 1013920-15-4

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 439.4826

Ref: IN-DA01V4FI

Vorolanib-d6

CAS : 1013920-15-4

Formule : C₂₃H₂₀D₆FN₅O₃

Masse moléculaire : 445.53

Ref: 4Z-V-094002

Vorolanib

CAS : 1013920-15-4

Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor.

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : 97.35%

Couleur et forme : Solid

Masse moléculaire : 439.4826

Ref: TM-T8491

Vorolanib

CAS : 1013920-15-4

(S,Z)-N-(1-(Dimethylcarbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : 99%

Masse moléculaire : 439.48

Ref: IN-DG01140959

Vorolanib

CAS : 1013920-15-4

Formule : C₂₃H₂₆FN₅O₃

Masse moléculaire : 439.49

Ref: 4Z-V-094001

Vorolanib

CAS : 1013920-15-4

Formule : C₂₃H₂₆FN₅O₃

Masse moléculaire : 439.5

Ref: BE-RMCV099000

Vorolanib

Produit contrôlé

CAS : 1013920-15-4

Formule : C₂₃H₂₆N₅O₃F

Couleur et forme : Neat

Masse moléculaire : 439.48

Ref: TR-V766025

Vorolanib-D6

Produit contrôlé

CAS : 1013920-15-4

Formule : C₂₃H₂₀D₆FN₅O₃

Couleur et forme : Neat

Masse moléculaire : 445.53

Ref: TR-V766027

X-82 (Vorolanib)

CAS : 1013920-15-4

Vorolanib is a small molecule that binds to the death receptor 4 (DR4) and inhibits angiogenesis. Vorolanib is a member of the everolimus group. This drug has been shown to inhibit tumor growth in a mouse model of metastatic cancer by blocking the activation of DR4, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib has also been shown to have anti-inflammatory properties. Vorolanib binds to the death receptor 4 (DR4) and inhibits angiogenesis by blocking activation of this protein, which signals cells to grow, and by inhibiting the production of pro-angiogenic factors. Vorolanib also has anti-inflammatory properties due to its ability to suppress myeloid derived suppressor cells (MDSCs).

Formule : C₂₃H₂₆FN₅O₃

Degré de pureté : Min. 95%

Masse moléculaire : 439.4 g/mol

Ref: 3D-NQB92015